Bigger revenues; smaller losses

Driven by gains in home HD with the System One cycler and the approval of nocturnal home HD, NxStage had higher revenues and smaller losses than expected for 2014—and has plans for an updated HD machine and PD.

Read the full article » | Posted 03-11-2015

Related Articles

• Watch a 2-minute video of Dr. Brigitte Schiller describing a paper on nocturnal home HD Posted 08-21-2026
• The Quanta Dialysis System for home HD is the first FDA 510(k) approved machine that offers high (500 mL/min) dialysate flow Posted 08-21-2026
• The American Kidney Fund’s Kidney Action Week: Future of Kidney Care is September 8-10. Posted 08-21-2026
• On August 9, CMS published “Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment.” Posted 08-21-2026